Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
We compare Dividend Growth ETFs to reveal the one with the lowest expense ratio, helping you maximize net returns without sacrificing growth.
28,176 articlesTwo bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
MercadoLibre stock slid 17% in the past month as JPMorgan cut its target to $2,100, citing fierce competition and mar...
Behind every AI breakthrough lies a power backstop. This article explains how Vertiv quietly powering every AI data c...
Brown University economist Mark Blyth outlines how a new Fed chair could steer policy through inflation and growth he...
The SPCX IPO surged on debut, lifting sentiment across equities. Investors are eyeing non-SPCX opportunities as the m...
The Premier League Lacrosse secures a $100 million funding round, bringing in entertainment and finance power to acce...
CoreWeave tumbled in morning trading as a legal case, insider sales and high leverage raise questions about its path ...
As IPO activity spikes, investors wonder if history is rhyming with 1929 and 2000. This guide breaks down the signals...
A sharp 34% June rally in Sandisk highlights a changing memory market. Explore the forces behind the move, what it me...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
U.S. GDP rose at a 1.4% annualized pace in the fourth quarter, a sharp deceleration from earlier quarters. The report...
As nephros (neph) 2025 earnings approach, investors weigh revenue growth, margins, and cash runway. This guide breaks...